The U.S. lost its measles elimination status on Tuesday after the Pan American Health Organization’s commission determined the disease had re-established itself following decades of control. This marks the first time since 2000 that the country failed to meet elimination criteria, which require no sustained measles transmission for more than 12 months.
Of these, 96% involved unvaccinated individuals or those with unknown vaccination status.
The U.S. had maintained measles-free status since 2000, a success attributed to widespread vaccination. However, outbreaks in 2019 nearly reversed that progress, and the past two years have seen larger clusters than in previous decades.
She noted that measles had already spread in communities, making the formal designation a confirmation of what officials had observed for years.
Jarbas Barbosa, director of PAHO, emphasized that elimination status is not guaranteed. The U.S. now joins Canada, Mexico, Bolivia, the U.K., and Spain—countries that have also lost their measles-free designation in recent years.
Declining vaccination rates fuel outbreaks
Declining vaccination rates lie at the root of the resurgence. While 95% coverage is needed to prevent outbreaks, nearly 20 states now have kindergarten vaccination rates below 90%. Local areas show even lower figures, leaving vulnerable populations exposed. Historically, high vaccination rates created herd immunity, but gaps have grown large enough to allow sustained transmission.
Noel Brewer, a public health expert at the University of North Carolina, criticized the absence of a coordinated elimination strategy. He stressed that the disease remains entirely preventable through vaccination.
The CDC has allocated $100 million to state and local health departments to address outbreaks, but experts argue the federal response has been inconsistent. Health Secretary Robert F. Kennedy Jr. has at times promoted vaccination while also spreading misinformation about vaccine risks, weakening public health efforts. His mixed messaging has allowed anti-vaccine rhetoric to gain ground.
She pointed out that current officials have not taken the necessary steps to maintain the status, unlike previous administrations.
The PAHO commission’s decision was based on a key technical criterion: sustained measles transmission for at least 12 months within the U.S. Unlike imported cases, which typically cause brief flare-ups, these outbreaks demonstrated the virus’s ability to spread continuously among unvaccinated groups. The CDC defines an outbreak as three or more linked cases, but recent clusters have involved dozens or even hundreds, overwhelming containment efforts that once worked in the U.S.
Tracking failures and deadly resurgence
The measles resurgence has also exposed flaws in the U.S. health system’s ability to track and respond to outbreaks. State and local health departments have reported inconsistencies in case counts, with Pennsylvania accusing the CDC of undercounting deaths. State data show 10 measles-associated fatalities this year, though the CDC’s official tally remains at six pending verification. This discrepancy reflects long-standing tensions between federal and state agencies, particularly in how they classify and report infectious disease cases. Experts note that even if the CDC’s count is accurate, the reappearance of measles deaths—rare in the U.S. since the 1990s, signals a return to pre-vaccination risks, though on a smaller scale.
Complications from measles have become a growing concern, particularly among pregnant women and newborns. Doctors have documented increased maternal and neonatal risks, including preterm births and severe infections in infants whose mothers were unvaccinated or underimmunized. The CDC’s vaccine schedule recommends two doses of the MMR vaccine, one at 12 months and a second between ages 4 and 6, but some physicians are now administering the first dose earlier to infants in high-risk areas. This adjustment reflects the urgency of the situation, though it also highlights the difficulties of reaching children in communities where vaccine skepticism is strong.
